You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 11, November 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Extract
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Macular Disorders
 •Retinal Detachment
 •Ophthalmological Disorders, Other
 •Alert me on articles by topic

Ocular Findings in a Patient With Hemophagocytic Syndrome

Edward W. Lee, MD; William F. Mieler, MD

Arch Ophthalmol. 2006;124:1656-1658.

Hemophagocytic syndrome is a rare disease characterized by fevers, hepatosplenomegaly, and pancytopenia. Additionally, there is increased proliferation and activation of macrophages, with hemophagocytosis seen histologically in the liver, spleen, and bone.1 Only 3 case reports2-4 of retinal findings associated with hemophagocytic syndrome have appeared in the literature. Two reports3-4 describe retinal hemorrhages, disc edema, and perivenous white patches, and the other2 describes acute posterior multifocal placoid pigment epitheliopathy–like findings. We report a case of hemophagocytic syndrome with ocular findings that, to our knowledge, have not been previously described in the literature.

Report of a Case

A 31-year-old African American woman admitted for fevers, 18-kg weight loss, hepatosplenomegaly, and ascites over a 6-month period was referred to the Department of Ophthalmology, University of Chicago, Chicago, Ill, for bilateral visual blurring of 1 week's duration. The patient was being treated with intravenous ceftazidime, fluconazole, and acyclovir for a suspected systemic infection. She denied symptoms of hair loss, headache, neck pain, tinnitus, or skin changes. Laboratory examination values were as follows: hemoglobin level, 95 g/L; white blood cell count, 1.7 x 109/L; platelet count, 15 x 109/L; lactate dehydrogenase level, 385 IU/L; and reticulocyte count, 5.7%. On ocular examination, her best-corrected visual acuity was 20/60 OD and 20/40 OS. Anterior segment examination results and intraocular pressures were normal. Funduscopic examination revealed multiple bilateral serous pigment epithelial detachments with macular edema. Fluorescein angiography showed corresponding pinpoint areas of leakage with late staining at the level of the pigment epithelium (Figure 1). Optical co herence tomography revealed a macular thickness of 845 µm OD and 439 µm OS. Consideration was given to treating the patient with systemic corticosteroids, although owing to concern of possible systemic infection, no treatment was instituted from the ocular standpoint.


Figure 600051
View larger version (67K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Color fundus photographs and fluorescein angiography transiting the right eye. In the right eye, there are diffuse macular edema and multiple serous pigment epithelial detachments in the posterior pole (A) as well as the nasal retina (B). C, Similar findings are seen in the left eye. Early (D) and late frames of the angiogram show pinpoint areas of leakage with eventual staining at the level of the retinal pigment epithelium with macular edema (E) in the right eye, involving the nasal retina as well (F). G, These findings are also seen in the left eye.


A week later, the patient underwent a diagnostic and therapeutic splenectomy with hepatic and regional lymph node biopsies. Surgical pathological examination revealed a diagnosis of hemophagocytic syndrome exemplified by marked erythrophagocytosis and histiocytosis in the spleen, liver, and lymph nodes without clonal expansion of T or B cells (Figure 2). Results of a follow-up ocular examination performed 2 weeks after the initial consultation were unchanged.


Figure 600052
View larger version (138K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 2. Histopathological examination of the spleen. A, Hemophagocytosis of mature erythrocytes and nucleated red blood cells by histiocytes (hematoxylin-eosin, original magnification x40). B, Magnification shows phagocytosis of mature erythrocytes (hematoxylin-eosin, original magnification x100). C, Magnification shows phagocytosis of nucleated red blood cells (hematoxylin-eosin, original magnification x100).


After stabilization of her condition, the patient was discharged to a physical rehabilitation center with the intention to start treatment for hemophagocytic syndrome as an outpatient. However, she was soon readmitted to intensive care at a different hospital for recurrent fevers, worsening ascites, and gastrointestinal bleeding. The patient developed multiple organ failure and died a month later. An autopsy could not be arranged.


Comment

Hemophagocytic syndrome results from uncontrolled T-lymphocyte activation with hyperproduction of TH1 proinflammatory cytokines, including interferon {gamma}, tumor necrosis factor {alpha}, interleukin 2, interleukin 10, and interleukin 12, causing macrophage activation.5 Macrophage proliferation and activation result in histiocytic infiltration of the lymph node sinuses and medullary cords, liver sinusoids and portal areas, splenic red pulp, and bone marrow with a high degree of hemophagocytosis seen on histopathological examination.1

The ocular features in our patient closely resemble those in ocular Vogt-Koyanagi-Harada disease, an inflammatory condition characterized by bilateral multiple retinal pigment epithelial detachments thought to be caused by an autoimmune reaction to melanocytes. It is typically found in darkly pigmented women aged 30 to 39 years. It can also be associated with systemic features including meningismus, hearing changes, and skin manifestations.6-7

To our knowledge, this is the first case report of a patient with hemophagocytic syndrome with features resembling ocular Vogt-Koyanagi-Harada disease. It is possible that the hyperinflammatory state of hemophagocytic syndrome causes a uveal inflammatory reaction with histiocytic infiltration resulting in ocular features similar to ocular Vogt-Koyanagi-Harada disease. An alternative explanation would be that the patient had 2 separate disease processes, although this would seem to be less likely.

In summary, we describe another possible ophthalmic manifestation of hemophagocytic syndrome. This can be added to the previously described abnormalities resembling leukemic retinopathy and acute multifocal placoid pigment epitheliopathy.


AUTHOR INFORMATION

Correspondence: Dr Mieler, Department of Ophthalmology and Visual Science, University of Chicago, 5841 S Maryland, MC 2114, Chicago, IL 60637 (wmieler{at}uchicago.edu).

Financial Disclosure: None reported.

Funding/Support: This article was supported in part by unrestricted grant 6-35233 from Research to Prevent Blindness, Inc.


REFERENCES

1. Tsuda H. Hemophagocytic syndrome in children and adults. Int J Hematol. 1997;65:215-226. FULL TEXT | ISI | PUBMED
2. Suzuki S, Mizota A, Adachi-Usami E. A case of hemophagocytic syndrome with retinal changes resembling APMPPE. Retina. 2002;22:219-221. FULL TEXT | ISI | PUBMED
3. Liao PM, Thompson JT. Ophthalmic manifestations of virus-associated hemophagocytic syndrome. Arch Ophthalmol. 1991;109:777. ISI | PUBMED
4. Kawamura H, Hatsukawa Y, Furukawa A, Inoue M, Kawa K. Ophthalmic findings in a case of hemophagocytic syndrome. Am J Ophthalmol. 1997;124:261-263. ISI | PUBMED
5. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome. Autoimmun Rev. 2004;3:69-75. FULL TEXT | PUBMED
6. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39:265-291. ISI | PUBMED
7. Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647-652. FULL TEXT | ISI | PUBMED

SECTION EDITOR: W. RICHARD GREEN, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.